SCHEMBL6653067

SCHEMBL6653067

CN(CCN1CCOCC1)c1ccncc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.47
CYP2D6 P10635 4/20 0.47
CYP2C19 P33261 4/20 0.47
LMNA P02545 4/20 0.42
CYP1A2 P05177 3/20 0.40
MAPT P10636 2/20 0.40
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
MAPK14 Q16539 2/20 0.40
NPC1 O15118 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
BLM P54132 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPK13 O15264 1/20 0.40
MAPK12 P53778 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648423 0.85 HRH3 (0.51) CYP3A4CYP1A2L3MBTL1
SCHEMBL6650144 0.84 CYP1A2 (0.53) CYP3A4CYP1A2L3MBTL1
SCHEMBL11440371 0.84 HTR7 (0.53) LMNAMAPTHSD17B10KDM4EALDH1A1
SCHEMBL13103802 0.83 POLB (0.48) ALDH1A1SMN1; SMN2
SCHEMBL2375260 0.81 SIGMAR1 (0.46) CYP3A4CYP2D6CYP2C19LMNACYP1A2
SCHEMBL23328246 0.80 EPHX2 (0.44) LMNACYP1A2ALDH1A1HPGDSMN1; SMN2
SCHEMBL24518600 0.79 SIGMAR1 (0.57) MAPTKDM4EALDH1A1HPGDRAB9A
SCHEMBL19623616 0.78 ALDH1A1 (0.42) CYP3A4CYP2D6CYP2C19LMNACYP1A2
SCHEMBL10591990 0.78 CYP2A6 (0.42) MAPTKDM4EALDH1A1HPGDNPC1
SCHEMBL3229035 0.76 ALDH1A1 (0.44) LMNAMAPTKDM4EALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1478645-A2 QUINOLINONE DERIVATIVES FOR TREATING CELL PROLIFERATION RELATED DISORDERS Amgen Inc. (US) 2004-11-24 EP disclosed
WO-2003066630-A2 QUINOLINONE DERIVATIVES FOR TREATING CELL PROLIFERATION RELATED DISORDERS AMGEN INC. (US) 2003-08-14 WO disclosed